Peritoneal Carcinoma
📧 Sign up to get email alerts when something new happens for Peritoneal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-22Clinical Trial Results: Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy [Phase 2]
Phase 2 trial assessing feasibility and quality of life of second-look laparoscopy with hyperthermic intraperitoneal chemotherapy in ovarian…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors [Phase 1]
Phase 1 update reporting safety, pharmacokinetics, and preliminary efficacy data for AI-061 in advanced solid tumors across multiple indicat…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study evaluating the combination of Azenosertib (ZN-c3) and Niraparib in pl…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers [Phase 1]
Phase 1b study evaluating SL-172154 in combination with other agents in platinum-resistant ovarian, fallopian tube, and primary peritoneal c…
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: NM32-2668 in Adult Patients With Selected Advanced Solid Tumors [Phase 1]
A Phase 1 trial of NM32-2668 in adults with selected advanced solid tumors has been terminated. The study enrolled multiple tumor types incl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum [Phase 2]
Phase 2 clinical trial update for I-131 Omburtamab in Desmoplastic Small Round Cell Tumor and other peritoneal cancers; the study is current…
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: CAR T Cells in Mesothelin Expressing Cancers [Phase 1]
Phase 1 study evaluating mesothelin-targeted CAR T cells in mesothelin-expressing cancers; results have been posted for a University of Penn…
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives
A completed clinical trial update examining factors influencing cascade genetic testing among women with hereditary gynecologic cancers and …
-
CLINICAL_TRIALS trial_result · 2023-11-08Clinical Trial Update: Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) [Phase 3]
Phase 3 evaluation of adding AL3818 to standard platinum-based chemotherapy for recurrent or metastatic gynecologic carcinomas is in progres…
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial [Phase 2, Phase 3]
Trial update for intraperitoneal therapy with carboplatin in epithelial ovarian cancer and related conditions; the study has completed phase…
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene [Phase 1, Phase 2]
Phase 1/2 clinical trial studying A166 in patients with various HER2-expressing or HER2-amplified cancers has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral Neuropathy [Phase 3]
A Phase 3 trial evaluating high-dose inorganic selenium for preventing chemotherapy-induced peripheral neuropathy in ovarian cancer patients…
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies [Phase 2]
Phase 2 trial update for enzalutamide in AR-positive ovarian, fallopian tube, or primary peritoneal cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission [Phase 1, Phase 2]
Phase 1/2 trial evaluating CDX-1401, Poly ICLC, and INCB024360 in remission for ovarian, fallopian tube, or primary peritoneal cancer comple…
-
CLINICAL_TRIALS trial_result · 2022-12-30Clinical Trial Update: Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer [Phase 2]
Phase 2 trial update on neoadjuvant chemotherapy for epithelial ovarian cancer with related fallopian tube and peritoneal carcinomas; curren…
-
CLINICAL_TRIALS trial_result · 2022-08-15Clinical Trial Update: A Study of Navicixizumab in Patients With Platinum Resistant Ovarian Cancer [Phase 3]
A Phase 3 clinical trial update for navicixizumab in platinum-resistant ovarian cancer is underway, with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-06-10Clinical Trial Update: First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer [Phase 2]
A Phase 2 trial evaluating first-line bevacizumab, carboplatin, and paclitaxel in stage III-IV ovarian, primary peritoneal, and fallopian tu…
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: A Study of Fluzoparib±Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on First-Line Platinum-Based Chemotherapy [Phase 3]
Phase 3 trial evaluating Fluzoparib with or without Apatinib versus placebo for maintenance in advanced ovarian cancer after response to fir…
-
CLINICAL_TRIALS trial_result · 2021-12-20Clinical Trial Update: Study on Pembrolizumab in Recurrent, Platinum Resistant, CPS >1 Positive Ovarian, Fallopian Tube and Primary Peritoneal Cancer Patients [Phase 2]
Phase 2 study evaluating pembrolizumab in recurrent, platinum-resistant ovarian, fallopian tube, and primary peritoneal cancers with CPS > 1…
-
CLINICAL_TRIALS trial_result · 2021-10-20Clinical Trial Update: Pemetrexed and Carboplatin in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial evaluating pemetrexed and carboplatin for recurrent ovarian, primary peritoneal, or fallopian tube cancer has complet…
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES) [Phase 2]
Phase 2 trial ARIES evaluating rucaparib with nivolumab in selected solid tumors has been terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers [Phase 2]
Phase 2 pilot study evaluating durvalumab with Vigil in advanced women's cancers has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy
Clinical trial evaluating whether fallopian tube cells collected by Cytuity can determine the presence of malignancy compared with removed o…
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma [Phase 2]
A Phase 2 trial evaluating chemotherapy in ovarian, fallopian tube, and peritoneal carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-10Clinical Trial Update: Trial of Trientine Plus Pegylated Liposomal Doxorubicin and Carboplatin in Epithelial Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating trientine plus pegylated liposomal doxorubicin and carboplatin in epithelial ovarian cancer and peritoneal/ fallo…